MDC.L Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 май 2023 @ 13:40):

Stats
Объем за сегодня	450.00
Средний объем	3.85M
Рыночная капитализация	3.69B
EPS	£0 ( 2023-11-14 )
Last Dividend	£3.00 ( 2022-08-04 )
Next Dividend	£0 ( N/A )
P/E	21.78
ATR14	£1.585 (0.32%)

Объем Корреляция

Длинно: 0.13 (neutral)

Кратко: -0.04 (neutral)

Signal:(60.912) Neutral

Mediclinic International Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Mediclinic International Корреляция - Валюта/Сырье

0.18
( neutral )

0.19
( neutral )

0.34
( neutral )

0.36
( neutral )

0.18
( neutral )

-0.17
( neutral )

Mediclinic International Финансовые показатели

Annual	2022
Выручка:	£3.23B
Валовая прибыль:	£505.00M (15.62 %)
EPS:	£0.210

FY	2022
Выручка:	£3.23B
Валовая прибыль:	£505.00M (15.62 %)
EPS:	£0.210

FY	2021
Выручка:	£3.00B
Валовая прибыль:	£426.00M (14.22 %)
EPS:	£0.0920

FY	2020
Выручка:	£3.08B
Валовая прибыль:	£1.12B (36.43 %)
EPS:	£-0.434

Financial Reports:

No articles found.

Mediclinic International Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£3.00 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Mediclinic International Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 8.34 - good (83.45%) | Divividend Growth Potential Score: 4.50 - Potential for dividend initiation, but uncertain (10.07%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£5.24	2016-06-16
Last Dividend	£3.00	2022-08-04
Next Dividend	£0	N/A
Payout Date	2022-08-26
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	£35.14	--
Avg. Dividend % Per Year	0.19%	--
Score	2.59	--
Div. Sustainability Score	8.34
Div.Growth Potential Score	4.50
Div. Directional Score	6.42	--

Next Divdend (Est)
(2024-11-04)

£0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

2.59

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2016	£0	0.00%
2017	£0	0.00%
2018	£7.90	1.17%
2019	£7.90	2.50%
2020	£0	0.00%
2021	£0	0.00%
2022	£3.00	0.94%
2023	£0	0.00%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
PSHD.L	No Dividend Player	2023-08-17	Annually	6	0.41%
GCP.L	Dividend King	2023-08-10	Quarterly	15	3.86%
AJB.L	Dividend Knight	2023-06-08	Semi-Annually	6	1.30%
TMIP.L	Dividend Junior	2023-08-10	Quarterly	2	0.02%
LTHM.L	Dividend Knight	2023-08-03	Semi-Annually	33	0.87%
COD.L	Dividend Knight	2023-06-12	Annually	23	2.36%
ROOF.L	Dividend Knight	2023-08-03	Quarterly	3	1.92%
HHV.L	Dividend Knight	2023-06-29	Semi-Annually	19	3.83%
AVON.L	Dividend Junior	2023-08-10	Semi-Annually	33	1.69%
VCAP.L	Dividend Knight	2023-09-14	Semi-Annually	4	3.56%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0467	1.500	9.07	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0210	1.200	9.30	10.00	[0 - 0.3]
returnOnEquityTTM	0.0507	1.500	-0.548	-0.822	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.791	0.800	6.04	4.84	[1 - 3]
quickRatioTTM	0.656	0.800	-0.846	-0.677	[0.8 - 2.5]
cashRatioTTM	0.649	1.500	7.51	10.00	[0.2 - 2]
debtRatioTTM	0.359	-1.500	4.01	-6.02	[0 - 0.6]
interestCoverageTTM	4.52	1.000	9.44	9.44	[3 - 30]
operatingCashFlowPerShareTTM	0.751	2.00	9.75	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.509	2.00	9.75	10.00	[0 - 20]
debtEquityRatioTTM	0.833	-1.500	6.67	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.156	1.000	-0.730	-0.730	[0.2 - 0.8]
operatingProfitMarginTTM	0.0866	1.000	-0.268	-0.268	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.214	1.000	9.92	9.92	[0.2 - 2]
assetTurnoverTTM	0.449	0.800	-0.343	-0.274	[0.5 - 2]
Total Score				8.34

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	24.46	1.000	7.63	0	[1 - 100]
returnOnEquityTTM	0.0507	2.50	-0.352	-0.822	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.509	2.00	9.83	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.751	2.00	9.75	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	19.07	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.171	1.000	8.22	0	[0.1 - 0.5]
Total Score				4.50

Mediclinic International

Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in the intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.